West Pharmaceutical Services, Inc. WST

NYS: WST | ISIN: US9553061055   30/04/2025
211,29 USD (-1,02%)
(-1,02%)   30/04/2025

24 april 2025 · West Announces Leadership Changes · Persbericht

24 april 2025 · West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend · Persbericht

10 april 2025 · West to Host First-Quarter 2025 Conference Call · Persbericht

5 maart 2025 · West to Participate in Upcoming Investor Conferences · Persbericht

5 september 2024 · West to Participate in Upcoming Investor Conference · Persbericht

25 juli 2024 · West Announces Second-Quarter 2024 Results · Persbericht

11 juli 2024 · West to Host Second-Quarter 2024 Conference Call · Persbericht

29 mei 2024 · West Introduces Daikyo Crystal Zenith® (CZ) Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy · Persbericht

28 mei 2024 · West to Participate in Upcoming Investor Conference · Persbericht

30 april 2024 · West to Participate in Upcoming Investor Conference · Persbericht

25 april 2024 · West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend · Persbericht

11 april 2024 · West to Host First-Quarter 2024 Conference Call · Persbericht

28 februari 2024 · West to Participate in Upcoming Investor Conferences · Persbericht

20 februari 2024 · West Announces Second-Quarter 2024 Dividend · Persbericht

15 februari 2024 · West Announces Fourth-Quarter and Full-Year 2023 Results · Persbericht

7 februari 2024 · West Named to Newsweek's America's Greatest Workplaces 2024 for Diversity · Persbericht

1 februari 2024 · West to Host Fourth-Quarter and Full-Year 2023 Conference Call · Persbericht

6 december 2023 · West Announces First-Quarter 2024 Dividend · Persbericht

4 december 2023 · West Receives FDA 510(k) Clearance for Vial2Bag Advanced® 13mm Admixture Device · Persbericht

1 november 2023 · West to Participate in Upcoming Investor Conferences · Persbericht

Mijn selecties